Home › Funds › Invenomic Capital Management LP › SLGN

Invenomic Capital Management LP position in SLGN

SILGAN HLDGS INC · Industrials

Invenomic Capital Management LP reported holding 632,992 shares of SLGN (SILGAN HLDGS INC) in its Q3 2026 13F filing — a position valued at US$22.0M, representing 1.09% of its reported portfolio and ranking #35 among its reported holdings. Invenomic Capital Management LP has disclosed SLGN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)632.99K sh
Reported value held$22.00M
Portfolio Weight1.09%
First reportedQ2 2026
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Invenomic Capital Management LP's SLGN position evolved

Invenomic Capital Management LP first disclosed a stake in SLGN in Q2 2026 at 131,660 shares (US$6.1M). The position peaked in Q3 2026 at 632,992 shares, worth US$22.0M. Across 2 filings, Invenomic Capital Management LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 632,992 shares valued at US$22.0M — an increase of 501,332 shares quarter over quarter.. Notable position changes include a 381% increase in Q3 2026 (shares rose 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 131.66K $6.11M New
Q3 2026 632.99K $22.00M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SLGN and 13F data

SLGN (SILGAN HLDGS INC) is a Industrials company. 22 other funds we track also report a position in SLGN — the largest reported positions include FULLER & THALER ASSET MANAGEMENT, INC. (US$204.0M), Alberta Investment Management Corp (US$56.8M), Atlas FRM LLC (US$52.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SLGN

All SLGN fund holders →

FAQ

How long has Invenomic Capital Management LP held SLGN?

Invenomic Capital Management LP has disclosed SLGN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Invenomic Capital Management LP's current position in SLGN?

As of Q3 2026, Invenomic Capital Management LP holds 632.99K shares of SLGN (SILGAN HLDGS INC), valued at $22.00M, representing 1.09% of its reported portfolio and ranking #35.

Has Invenomic Capital Management LP been buying or selling SLGN?

In the latest 13F filing (Q3 2026), Invenomic Capital Management LP increased its position in SLGN. The position peaked in Q3 2026 at 632.99K shares.

Which other funds hold SLGN?

Other major institutional holders of SLGN include FULLER & THALER ASSET MANAGEMENT, INC., Alberta Investment Management Corp, Atlas FRM LLC, among 22 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.